Literature DB >> 26351483

The Effects of Cyclin D1 and Bcl-2 Expressıon on Aggressive Behavior in Basal Cell and Basosquamous Carcinoma.

Oya N Sivrikoz1, Gülşen Kandiloğlu2.   

Abstract

BACKGROUND AND
OBJECTIVE: Clinical behavior of basal cell carcinoma (BCC) is known to be different according to histological growth pattern and basosquamous cell carcinomas (BSC) are known with their aggressive behavior and metastatic capacity. In this study, we evaluated bcl-2 and cyclin D1 expressions in BCC and BSC cases comparatively, to explore their predictive value on the aggressive behavior of these tumors.
METHODS: One hundred tumors belong to 92 patients diagnosed as basal cell carcinoma and basosquamous carcinoma were studied. Basal cell carcinomas were classified as aggressive and non-aggressive types according to growth pattern. Number of Cyclin D1 and bcl-2 positive cells in immunohistochemically stained serial sections were scored as low (0-1 +) and high (2 and 3+) in all tumors.
RESULTS: A statistically significant difference was found between non-aggressive (nodular type) and aggressive types (micronodular, infiltrative types and BSC) for these markers ( P <0.005). Cyclin D1 was higher in the aggressive group, while bcl-2 was lower in the aggressive group compared to the non-aggressive group.
CONCLUSION: Higher Cyclin D1 and lower bcl-2 scores was correlated with aggressive tumor types and these results could be used as markers to predict aggressive behavior in BCC and BSCs.

Entities:  

Keywords:  Aggression; Basal Cell Carcinoma; Basosquamous Carcinoma; Bcl-2 Gene; Cyclin D1

Year:  2015        PMID: 26351483      PMCID: PMC4539776     

Source DB:  PubMed          Journal:  Iran J Pathol        ISSN: 1735-5303


  26 in total

1.  bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas.

Authors:  P K Ramdial; A Madaree; R Reddy; R Chetty
Journal:  J Cutan Pathol       Date:  2000-07       Impact factor: 1.587

2.  Cutaneous basosquamous carcinoma. Review of the literature and report of 35 cases.

Authors:  D M Borel
Journal:  Arch Pathol       Date:  1973-05

3.  A dose-response curve for sun exposure and basal cell carcinoma.

Authors:  A Kricker; B K Armstrong; D R English; P J Heenan
Journal:  Int J Cancer       Date:  1995-02-08       Impact factor: 7.396

4.  Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin.

Authors:  T W Beer; P Shepherd; J M Theaker
Journal:  Histopathology       Date:  2000-09       Impact factor: 5.087

Review 5.  Basal cell carcinoma: a dermatopathological and molecular biological update.

Authors:  G Saldanha; A Fletcher; D N Slater
Journal:  Br J Dermatol       Date:  2003-02       Impact factor: 9.302

6.  Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms.

Authors:  M Sexton; D B Jones; M E Maloney
Journal:  J Am Acad Dermatol       Date:  1990-12       Impact factor: 11.527

7.  Bcl-2-related proteins, alpha-smooth muscle actin and amyloid deposits in aggressive and non-aggressive basal cell carcinomas.

Authors:  Onder Bozdogan; Emel Erkek; Pinar Atasoy; Mukadder Koçak; Ahu Birol; Muzaffer Caydere
Journal:  Acta Derm Venereol       Date:  2002       Impact factor: 4.437

8.  Basosquamous cell carcinoma of the skin with metastases.

Authors:  J Lopes de Faria; P H Nunes
Journal:  Histopathology       Date:  1988-01       Impact factor: 5.087

9.  Expression of beta-catenin in basal cell carcinoma.

Authors:  M El-Bahrawy; N El-Masry; M Alison; R Poulsom; M Fallowfield
Journal:  Br J Dermatol       Date:  2003-05       Impact factor: 9.302

Review 10.  Basal cell carcinoma. Identification and treatment of the high-risk patient.

Authors:  H W Randle
Journal:  Dermatol Surg       Date:  1996-03       Impact factor: 3.398

View more
  3 in total

1.  Caspase-3, p53 and Bcl-2 expression in basal cell carcinoma of the eyelid.

Authors:  Efe Koyun; Remzi Karadag; Seyma Ozkanli; Serpil Oguztuzun; Arzu Kaya Kocdogan; Isilay Ozsoy
Journal:  Postepy Dermatol Alergol       Date:  2020-09-02       Impact factor: 1.837

2.  Role of Bcl-2, p53, and Ki-67 expression in basal cell carcinoma and their association with aggressive and non-aggressive histological phenotypes.

Authors:  Raúl Gerardo Mendez-Flores; Diana Emilia Martínez-Fernández; Diego Ernesto Vega-De la Torre; Marianela Zambrano-Román; José Francisco Muńoz-Valle; Mario Gaston Toledo-Lelevier; Elizabeth Guevara-Gutiérrez; Marisol Ramírez-Padilla; Emmanuel Valdés-Alvarado
Journal:  Postepy Dermatol Alergol       Date:  2022-07-14       Impact factor: 1.664

3.  Inhibition of bcl-2 and cox-2 Protein Expression after Local Application of a New Carmustine-Loaded Clinoptilolite-Based Delivery System in a Chemically Induced Skin Cancer Model in Mice.

Authors:  Cristina Mihaela Ghiciuc; Aurel Lulu Strat; Lacramioara Ochiuz; Catalina Elena Lupusoru; Maria Ignat; Aurelia Vasile; Alexandru Grigorovici; Iulian Stoleriu; Carmen Solcan
Journal:  Molecules       Date:  2017-11-20       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.